YU67195A - Lipozomni preparat koji sadrži selegilin i/ili njegovu so - Google Patents
Lipozomni preparat koji sadrži selegilin i/ili njegovu soInfo
- Publication number
- YU67195A YU67195A YU67195A YU67195A YU67195A YU 67195 A YU67195 A YU 67195A YU 67195 A YU67195 A YU 67195A YU 67195 A YU67195 A YU 67195A YU 67195 A YU67195 A YU 67195A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- weight
- liposomic
- pct
- selegilin
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Detergent Compositions (AREA)
- Dental Preparations (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Ovaj pronalazak obezbeđuje lipozomni preparat koji sadrži kao aktivni sastojak (-)-N-alfa-(2-propinilfeniletilamin) (selegilin) i/ili njegovu so. Ovaj preparat sadrži: 0,1-40 mas.% selegilina i/ili njegove soli, 2-40 mas.% lipida, poželjno fosfolipida, 0-10 mas.% holesterola, 0-20 mas.% alkohola 0-25 mas.% glikola, 0-3 mas.% antioksidansa, 0-3 mas.% konzervansa, 0-20 mas.% agensa koji utiče na viskoznost, 0-50 mas.% ciklodekstrina ili derivata ciklodekstrina, 30-90 mas.% vode. Ovaj pronalazak se odnosi na farmaceutski preparat koji sadrži opisan lipozomni preparat i ako se želi, uobičajene agense za punjenje ili razblaživanje i druge pomoćne agense, poželjno u oralnom, parenteralnom ili transdermalnom obliku. Ovaj pronalazak obezbeđuje postupak za dobijanje lipozomnih preparata koji sadrže selegilin i/ili njegovu so. Stoga lipozomni preparat ovog pronalaska može biti dat za tretiranje Alzheimerove bolesti, Parkinsonove bolesti, depresije, šloga, bolesti kretanja ili mielitisa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9403073A HU223475B1 (hu) | 1994-10-24 | 1994-10-24 | Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására |
Publications (2)
Publication Number | Publication Date |
---|---|
YU67195A true YU67195A (sh) | 1998-07-10 |
YU49313B YU49313B (sh) | 2005-06-10 |
Family
ID=10985697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU67195A YU49313B (sh) | 1994-10-24 | 1995-10-25 | Lipozomni preparat koji sadrži selegilin i/ili njegovu so |
Country Status (30)
Country | Link |
---|---|
US (1) | US5888536A (sh) |
EP (1) | EP0788349B1 (sh) |
JP (1) | JPH10507749A (sh) |
KR (1) | KR100313149B1 (sh) |
CN (1) | CN1084186C (sh) |
AT (1) | ATE205387T1 (sh) |
AU (1) | AU691348B2 (sh) |
BG (1) | BG63327B1 (sh) |
BR (1) | BR9509517A (sh) |
CA (1) | CA2203513C (sh) |
CZ (1) | CZ287349B6 (sh) |
DE (1) | DE69522701T2 (sh) |
DK (1) | DK0788349T3 (sh) |
EE (1) | EE03418B1 (sh) |
ES (1) | ES2160718T3 (sh) |
FI (1) | FI971743A (sh) |
HU (1) | HU223475B1 (sh) |
IL (1) | IL115754A (sh) |
NO (1) | NO316354B1 (sh) |
NZ (1) | NZ294660A (sh) |
PL (1) | PL183104B1 (sh) |
PT (1) | PT788349E (sh) |
RO (1) | RO116768B1 (sh) |
RU (1) | RU2159106C2 (sh) |
SK (1) | SK281599B6 (sh) |
TW (1) | TW412420B (sh) |
UA (1) | UA44289C2 (sh) |
WO (1) | WO1996012472A1 (sh) |
YU (1) | YU49313B (sh) |
ZA (1) | ZA958999B (sh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1052983A2 (en) * | 1998-01-27 | 2000-11-22 | Thomas N. Thomas | Use of an mao-a or mao-b inhibitor for the treatment of vascular disorders |
DE19814257A1 (de) | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
GB9815785D0 (en) * | 1998-07-20 | 1998-09-16 | Cerebrus Ltd | Chemical compounds |
CA2536393A1 (en) * | 2003-09-09 | 2005-06-16 | Gilead Sciences, Inc. | Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample |
US20080233053A1 (en) * | 2005-02-07 | 2008-09-25 | Pharmalight Inc. | Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients |
CN1813679A (zh) * | 2005-11-30 | 2006-08-09 | 上海医药(集团)有限公司 | 一种紫杉烷脂质体冻干组合物及其制备方法 |
US9445975B2 (en) * | 2008-10-03 | 2016-09-20 | Access Business Group International, Llc | Composition and method for preparing stable unilamellar liposomal suspension |
JP5693026B2 (ja) * | 2010-03-12 | 2015-04-01 | 株式会社フジモト・コーポレーション | セレギリン含有貼付製剤 |
JP5623102B2 (ja) * | 2010-03-12 | 2014-11-12 | 株式会社フジモト・コーポレーション | セレギリン含有貼付製剤 |
WO2013168167A1 (en) | 2012-05-10 | 2013-11-14 | Painreform Ltd. | Depot formulations of a hydrophobic active ingredient and methods for preparation thereof |
WO2016051424A1 (en) * | 2014-09-29 | 2016-04-07 | Council Of Scientific & Industrial Research | A formulation useful for delivery of neuro protecting agent |
PL3600435T3 (pl) * | 2017-03-23 | 2024-06-17 | Lipid Systems Sp. Z.O.O. | Wysokowydajne kapsułkowanie związków hydrofilnych w liposomach jednowarstwowych |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH588887A5 (sh) * | 1974-07-19 | 1977-06-15 | Battelle Memorial Institute | |
US4485054A (en) * | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
US4761288A (en) * | 1984-09-24 | 1988-08-02 | Mezei Associates Limited | Multiphase liposomal drug delivery system |
GB8807504D0 (en) * | 1988-03-29 | 1988-05-05 | Sandoz Ltd | Improvements in/relating to organic compounds |
US4937078A (en) * | 1988-08-26 | 1990-06-26 | Mezei Associates Limited | Liposomal local anesthetic and analgesic products |
FR2713087B1 (fr) * | 1993-11-30 | 1996-02-23 | Saurat Jean Hilaire | Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis. |
-
1994
- 1994-10-24 HU HU9403073A patent/HU223475B1/hu not_active IP Right Cessation
-
1995
- 1995-10-20 CZ CZ19971147A patent/CZ287349B6/cs not_active IP Right Cessation
- 1995-10-20 KR KR1019970702682A patent/KR100313149B1/ko not_active IP Right Cessation
- 1995-10-20 BR BR9509517A patent/BR9509517A/pt not_active IP Right Cessation
- 1995-10-20 WO PCT/HU1995/000052 patent/WO1996012472A1/en active IP Right Grant
- 1995-10-20 AT AT95935530T patent/ATE205387T1/de not_active IP Right Cessation
- 1995-10-20 DK DK95935530T patent/DK0788349T3/da active
- 1995-10-20 RU RU97108051/14A patent/RU2159106C2/ru not_active IP Right Cessation
- 1995-10-20 UA UA97052395A patent/UA44289C2/uk unknown
- 1995-10-20 DE DE69522701T patent/DE69522701T2/de not_active Expired - Fee Related
- 1995-10-20 SK SK517-97A patent/SK281599B6/sk unknown
- 1995-10-20 US US08/817,433 patent/US5888536A/en not_active Expired - Fee Related
- 1995-10-20 PL PL95319875A patent/PL183104B1/pl not_active IP Right Cessation
- 1995-10-20 ES ES95935530T patent/ES2160718T3/es not_active Expired - Lifetime
- 1995-10-20 JP JP8513742A patent/JPH10507749A/ja active Pending
- 1995-10-20 CN CN95195853A patent/CN1084186C/zh not_active Expired - Fee Related
- 1995-10-20 NZ NZ294660A patent/NZ294660A/en not_active IP Right Cessation
- 1995-10-20 AU AU37518/95A patent/AU691348B2/en not_active Ceased
- 1995-10-20 EP EP95935530A patent/EP0788349B1/en not_active Expired - Lifetime
- 1995-10-20 CA CA002203513A patent/CA2203513C/en not_active Expired - Fee Related
- 1995-10-20 PT PT95935530T patent/PT788349E/pt unknown
- 1995-10-20 EE EE9700102A patent/EE03418B1/xx not_active IP Right Cessation
- 1995-10-20 RO RO97-00792A patent/RO116768B1/ro unknown
- 1995-10-24 IL IL11575495A patent/IL115754A/xx not_active IP Right Cessation
- 1995-10-24 ZA ZA958999A patent/ZA958999B/xx unknown
- 1995-10-24 TW TW084111224A patent/TW412420B/zh not_active IP Right Cessation
- 1995-10-25 YU YU67195A patent/YU49313B/sh unknown
-
1997
- 1997-04-22 BG BG101432A patent/BG63327B1/bg unknown
- 1997-04-23 FI FI971743A patent/FI971743A/fi not_active IP Right Cessation
- 1997-04-23 NO NO19971870A patent/NO316354B1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2301189T3 (es) | Agentes de limpieza antimicrobianos. | |
JP5616620B2 (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
NO974023L (no) | Topisk appliserbart farmasöytisk preparat, fremgangsmåte for dets fremstilling og anvendelse derav | |
BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
JP2002003364A (ja) | 点眼剤、眼科用組成物及び吸着抑制方法 | |
YU67195A (sh) | Lipozomni preparat koji sadrži selegilin i/ili njegovu so | |
JP3142842B1 (ja) | 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法 | |
JP2018203792A (ja) | 眼の異物感改善剤 | |
JP2018188486A (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤 | |
JP3175742B1 (ja) | コンタクトレンズ用眼科用組成物 | |
JP5725786B2 (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
JP2011153127A (ja) | 眼科用組成物 | |
JP2011111441A (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
JP5650864B2 (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
JP2004203824A (ja) | 鼻腔用組成物及びその使用方法 | |
JP2005075735A (ja) | オキシメタゾリン含有組成物 | |
JP2002104971A (ja) | 眼科用組成物 | |
JP2001187731A5 (sh) | ||
JPH11180872A (ja) | 骨代謝改善剤 |